Minato A, Furubayashi N, Nagata Y, Tomoda T, et al. Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study. Curr Oncol 2024;31:862-871.
PMID: 38392058